
Safety of regadenoson with theophylline reversal during dynamic computed tomography perfusion and magnetic resonance imaging in patients with coronary artery disease
Author(s) -
Anna Oleksiak,
Mariusz Kruk,
Mateusz Śpiewak,
Barbara Miłosz-Wieczorek,
Magdalena Marczak,
Marcin Demkow,
Cezary Kępka
Publication year - 2020
Publication title -
kardiologia polska
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.527
H-Index - 34
eISSN - 1897-4279
pISSN - 0022-9032
DOI - 10.33963/kp.15356
Subject(s) - regadenoson , medicine , myocardial perfusion imaging , coronary artery disease , cardiology , perfusion , aminophylline , theophylline , interquartile range , perfusion scanning , anesthesia
The use of regadenoson in dynamic computed tomography perfusion (CTP) and magnetic resonance myocardial perfusion imaging (MR MPI) is off‑label.